HansBiomed Corporation (042520) — Cash Flow Quality Index
HansBiomed Corporation (042520) has a Cash Flow Quality Index of 1.70x as of June 2024. Operating cash flow of ₩159.13 Million exceeds net income of ₩93.69 Million, indicating high earnings quality where cash backs reported profits. Explore 042520 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HansBiomed Corporation Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for HansBiomed Corporation across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see HansBiomed Corporation operating cash flow efficiency.
Annual Cash Flow Quality Index for HansBiomed Corporation (2012–2022)
Year-by-year earnings quality comparison for HansBiomed Corporation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.69x | ₩-4.27 Billion | ₩6.15 Billion | ▼ -188.7% |
| 2019 | 0.78x | ₩7.71 Billion | ₩9.85 Billion | ▼ -37.4% |
| 2018 | 1.25x | ₩5.20 Billion | ₩4.16 Billion | ▲ +75.0% |
| 2017 | 0.72x | ₩5.60 Billion | ₩7.83 Billion | ▲ +1179.4% |
| 2016 | -0.07x | ₩-316.10 Million | ₩4.77 Billion | ▼ -109.4% |
| 2015 | 0.71x | ₩3.47 Billion | ₩4.91 Billion | ▲ +19.8% |
| 2014 | 0.59x | ₩2.06 Billion | ₩3.50 Billion | ▼ -13.2% |
| 2013 | 0.68x | ₩2.33 Billion | ₩3.43 Billion | ▲ +14.0% |
| 2012 | 0.60x | ₩1.50 Billion | ₩2.52 Billion | — |